| #46 |
Derek O'Hagan |
Glaxosmithkline Biologicals Sa |
1 |
| #46 |
Huabiao Chen |
The General Hospital |
1 |
| #46 |
SangOh Jung |
Ses Holdings Pte. |
1 |
| #46 |
Ruan Zhang |
Flodesign Sonics |
1 |
| #46 |
Alex Goldblatt |
Sunflower Therapeutics, Pbc |
1 |
| #46 |
Mark Totman |
Zoll Medical |
1 |
| #46 |
Madhu Mondal |
Forma Therapeutics |
1 |
| #46 |
Jeremy Brent Ratz |
Edwards Lifesciences Cardiaq |
1 |
| #46 |
Tanya S. Kanigan |
Thermo Fisher |
1 |
| #46 |
Andrew Shein |
Irobot |
1 |
| #46 |
David Perticone |
L-3 Communications Security & Detection Systems |
1 |
| #46 |
Lawrence Fishman |
Fishman Transducers |
1 |
| #46 |
Alan D'Andrea |
Dana-Farber Cancer Institute |
1 |
| #46 |
Peter Stewart Easton |
Aurea Software |
1 |
| #46 |
Yongbo Hu |
Millennium Pharmaceuticals |
1 |
| #46 |
Jonah Egenolf |
Ab Initio Technology |
1 |
| #46 |
Yansheng Liu |
Tetraphase Pharmaceuticals |
1 |
| #46 |
Gerhard Sollner |
RTX (Raytheon) |
1 |
| #46 |
Haiyan Zhou |
Verizon |
1 |
| #46 |
Noah Smick |
Neutron Therapeutics |
1 |
| #46 |
Jon David Neckes |
Bank of America |
1 |
| #46 |
Qing Huai |
— |
1 |
| #46 |
David Clark |
Aldeyra Therapeutics |
1 |
| #46 |
Qianhe ZHOU |
Foghorn Therapeutics |
1 |
| #46 |
Joshua FORMAN |
Vital Biosciences |
1 |
| #46 |
Martin M. Wattenberg |
IBM |
1 |